• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
5-(9-Isopropyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine

5-(9-Isopropyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine

Product ID I0010
Cas No. 1246535-95-4
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $110.00 In stock
25 mg $329.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Desmethyl VS5584 Is an intermediate in the synthesis of purine analogs and potential tyrosine kinase inhibitor. This analog is a highly selective PI3K/mTOR kinase inhibitor.

Product Info

Cas No.

1246535-95-4

Purity

≥98%

Formula

C16H20N8O

Formula Wt.

340.39

IUPAC Name

5-[9-Isopropyl-2-(4-morpholinyl)-9H-purin-6-yl]-2-pyrimidinamine

Synonym

Desmethyl-VS-5584, Desmethyl VS5584, Desmethyl VS 5584, VS-5584 Analog

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

I0010 MSDS PDF

Info Sheet

I0010 Info Sheet PDF

References

Zhou C, Li X, He A, et al. Development of a UPLC-MS/MS method for the quantification of VS-5584 and its application in pharmacokinetic studies in rats. J Anal Methods Chem. 2020 Dec 16;2020:8811522. PMID: 33381351.

Chen Y, Tsai H, Tsai Y, et al. VS-5584, a PI3K/mTOR dual inhibitor, exerts antitumor effects on neuroblastomas in vitro and in vivo. J Pediatr Surg. 2021 Aug;56(8):1441-1448. PMID: 33189297.

Xu M, Xu L, Wang Y, et al. BRD4 inhibition sensitizes renal cell carcinoma cells to the PI3K/mTOR dual inhibitor VS-5584. Aging (Albany NY). 2020 Oct 13;12(19):19147-19158. PMID: 33051401.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G7342

    GSK-2126458

    p110α PI3K and mTOR inhibitor.

    ≥99%
  • L1340

    LDK378

    ALK and IGF-1R inhibitor.

    ≥99%
  • R0110

    Ractopamine Hydrochloride

    β1/2-adrenergic agonist.

    ≥97%
  • M324083

    Micafungin

    Echinocandin

    ≥95%
  • L8261

    Lupeol

    Triterpene; potential tyrosinase inhibitor.

    ≥98%
  • D0182

    Daunorubicin Hydrochloride

    Anthracycline, DNA intercalator; topoisomerase ...

    ≥98%
  • N6272

    NPS-2143 Hydrochloride

    Ca2+-sensing receptor antagonist.

    ≥99%
  • C3260

    Ciprofibrate

    Fibrate; PPARα agonist.

    ≥98%
  • N1868

    Neratinib

    EGFR inhibitor.

    ≥98%
  • E0073

    Ebselen

    Synthetic glutathione peroxidase mimetic; yeast...

    ≥99%
  • T1952

    Tenuazonic Acid Copper Salt

    Mycotoxin produced by Alternaria; photosynthesi...

    ≥98%
  • G124090

    GDC-6036

    KRAS inhibitor

    ≥98%
  • A2046

    Aflatoxin B2

    Mycotoxin produced by species of Aspergillus; D...

    ≥98%
  • A5044

    Amlodipine Besylate

    Dihydropyridine, FIASMA; L-type Ca2+ channel bl...

    ≥98%
  • T0142

    TAK-733

    MEK inhibitor.

    ≥98%
  • L283080

    LHC-165

    TLR7 agonist

    ≥99%
  • T3185

    Thymidine

    Pyrimidine nucleoside base, pairs with adenosin...

    ≥98%
  • C211324

    CFI-400945

    PLK4 inhibitor.

    ≥98%
  • D5792

    Doxofylline

    Xanthine derivative; PDE inhibitor.

    ≥98%
  • B4518

    Bleomycin Sulfate

    Mixture of glycopeptide bleomycin sulfate salts...

    ≥90%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only